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cDNAs encoding the rat liver regulatory protein of glucokinase were cloned and sequenced. The deduced protein contains 568 amino acids for 
a molecular mass of 62,867 Da. Northern blot analysis showed the presence of a major RNA species of 2.35 kb in rat liver. No signal was observed 
with muscle, brain, heart, testis, intestine or spleen RNA. Recombinant regulatory protein expressed in Escherichia~coli was insoluble and inactive, 
and was presumably contained in inclusion bodies. Western blot analysis howed that the recombinant protein was recognized by antibodies raised 
against regulatory protein puri8ed from rat liver. 
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1. INTRODUCTION 
Rat liver contains a regulatory protein, which inhibits 
glucokinase competitively with respect to glucose [l]. 
The effect of this protein is greatly reinforced by fruc- 
tose 6-phosphate and antagonized by fructose l-phos- 
phate. The regulatory protein has been purified to near- 
homogeneity and identified as a 62 kDa polypeptide [2]. 
It inhibits glucokinase by forming an inactive complex 
with this enzyme (reviewed in [3]). The regulatory pro- 
tein is present in the livers of species that have glucoki- 
nase, although not in others (Vandercammen and Van 
Schaftingen, unpublished results). There are also indica- 
tions that regulatory protein is present in B-cells of 
Langerhans islets [4], where glucokinase plays the role 
of a glucose-sensor [5]. Here, we report the cloning of 
cDNAs encoding rat liver regulatory protein. 
were then electroblotted onto Immobilon Membranes (Millipore 
Corp.), which were submitted to in situ digestion with trypsin [7J The 
generated peptides were purified by HPLC as in [7] on a 0.46 x 25 cm 
C,s reversed phase column. Peptides were detected by absorbance at 
214 nm and manually collected. Sequence analysis was carried out 
with a 477A Applied Biosystems pulsed liquid phase sequenator 
equipped with an on-line phenylthiohydantoin amino acid analyser 
(model 120A). For the sequencing of the amino-terminal end, regula- 
tory protein was purified as in [8] and used without being submitted 
to electrophoresis. 
2.2. Obtention of a DNA probe 
2. MATERIALS AND METHODS 
We used the protocols described in [9] for all standard molecular 
biology techniques. Rat liver cDNA was prepared by reverse tran- 
scription of total rat liver RNA (see section 2.4) with an oligo-dT 
primer. A PCR with 1 ng of cDNA and 25 pmol of two degenerate 
primers [5’-CGAAGCTTTACCAGCATGTGAT(TCA)GA(AG)A- 
C(TGCA)CC-3’ and S-CGGGATCCTTCTCTGTGATIGG- 
(TGCA)AC(TGCA)GC-31 was performed as described in [lo] with 
an annealing temperature of 37’C during 3 cycles and of 52’C during 
30 cycles. The PCR product was purified by electrophoresis in a 
low-melting agarose gel, digested overnight with Hind111 and BarnHI, 
cloned in pBluescript KS(+) (Stratagene) and sequenced. 
Radiolabelled compounds, nitrocellulose filters (Hybond C-extra), 
nylon filters (Hybond-N) and Megaprime labelling kit were from 
Amersham, restriction and modifying enzymes from Boehringer, 
GeneAmp DNA Amplification Kit from Perkin Elmer Cetus, and T7 
Sequencing kit from Pharmacia. 
2.3. Isolation and sequencing of cDNA clones 
2.1. Protein sequencing 
Rat liver regulatory protein purified to near-homogeneity [2] was 
submitted to two-dimensional gel electrophoresis [6]. The proteins 
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About 100,000 clones of a rat liver cDNA library (Clontech, no. 
RLlOOlb) constructed in Igtll were plated with E. coli Y1088 as host, 
and grown overnight. The DNA from the plaques was transferred to 
nitrocellulose filters, which were subsequently prehybridized in a solu- 
tion containing 6 x SSC, 5 x Denhardt’s solution, 0.5% SDS, 0.1 mg/ 
ml denatured herring sperm DNA, 1 mM EDTA and 10 mM sodium 
phosphate buffer, pH 7.1. Hybridization was performed overnight at 
65°C with 200,000 dpm/ml of the cloned probe (speci8c activity: 
700,000 dpm/ng DNA), labelled by random priming. The filters were 
rinsed 3 x 5 min in 2 x SSC, 0.1% SDS at room temperature, washed 
30 min with 0.2 x SSC, 0.1% SDS at 65’C and autoradiographed. 
Positive plaques were picked up and submitted to a secondary screen- 
ing. Their phage DNA was purified and the EcoRI inserts were sub- 
cloned in pBlueScript KS(+). 
About 100,000 phages of a second library constructed in ilZAPI1 
(Stratagene, no. 936513) were plated with E. coli XLlBlue as host and 
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screened as above, with a probe corresponding to nucleotides l-745 
of PBS-LPR17, a clone obtained in the first screening. The pBlueScript 
II KS(+) phagemids containing the cDNA were excised in vivo with 
ExAssist Phage Helper as described by the manufacturer. 
Plasmid DNA was purified by the boiling lysis method [l l] and 
sequenced on both strands after alkaline denaturation [12]. 
2.4. RNA preparation and Northern blot analysis 
Total RNA was prepared from various tissues by the guanidinium 
isothiocyanate/CsCl procedure, electrophoresed in 1% agarose/for- 
maldehyde gels and transferred to nylon filters by capillarity. The 
filters were prehybridized in 50% formamide, 5 x SSPE (1 x SSPE is 
180 mM NaCl, 10 mM NaH,PO,, 1 mM EDTA, pH 7.5), 0.5% SDS, 
5 x Denhardt’s olution and 0.5 mg/ml denatured herring sperm DNA 
and hybridized at 42’C with a probe corresponding to nucleotides 
l-l,800 of pBSLPRl7 labelled by random priming (1.5 x lo6 cpm/ 
ml). The filters were washed 3 x 30 min at 50°C in 1 x SSC, 0.1% SDS 
and autoradiographed. 
2.5. Expression of a recombinant protein 
The protein was expressed in the expression system of Studier and 
Moffatt [ 131. A NdeI restriction site was introduced at the initial ATG 
in the coding sequence of pBSLPRl7 by PCR mutagenesis [14] with 
a primer containing EcoRI and NdeI sites followed by the first 18 
nucleotides of the coding sequence and a reverse primer corresponding 
to nucleotides 1,135-l) 118 of PBS-LPR 17. An EcoRI-PvuII fragment 
containing the first 368 nucleotides of the coding sequence was excised 
from the amplified DNA and ligated to a fragment derived from 
PBS-ZPRl, which contained the rest of the coding sequence. The 
resulting construct was inserted in pBlueScript KS(+), checked by 
sequencing and inserted in pET3a expression plasmid. After cloning 
and amplification in XLl-Blue, the resulting plasmid, termed PET- 
PR, was used to transform competent E. coli BL21 (DE3)pLysS. The 
cells were grown in M9 medium containing 1% glucose, 25 &ml 
ampicillin and 30 &ml chloramphenicol until A, reached 0.5. The 
inducer isopropyl-1-thio#-D-galactopyranoside (IPTG) was then 
added to final concentrations ranging from 0.01 to 0.4 mM and the 
cultures were incubated overnight at 22’C or 3 h at 37°C. The cells 
were pelleted by centrifugation, washed in cold buffer B (25 mM 
HEPES, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol) and centrifuged 
again. They were resuspended in cold buffer B containing 1 mM 
phenylmethanesulfonyl fluoride, 2.5 &ml leupeptin, 2.5 &ml anti- 
pain, 2.5 ,&s$ml aprotinin, 2 mM ZnCl, and 2.5 &ml pepstatin, and 
disrupted in a French Press (Aminco) at 96 MPa. Western blots were 
performed as in [15], using a rabbit antibody directed against rat liver 
regulatory protein, and revealed as in [16]. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and characterization of regulatory protein 
clones 
As shown in Fig. 1B the longest of the 4 tryptic pep- 
tides that were sequenced contained 27 amino acids. 
The extremities of this peptide were used to design PCR 
primers, which were degenerate at their 3’ end. A PCR 
reaction was performed with rat liver cDNA and a sin- 
gle 90 bp product was cloned and sequenced. The se- 
quences of three clones that were determined matched 
that of the 27 amino acid peptide. 
Using the cloned PCR product as a probe, we 
screened about 100,000 plaques of a rat liver cDNA 
library from Clontech, and obtained ten positive clones. 
The longest of them (‘pBSLPR17) was completely se- 
quenced (Fig. 1A) and found to contain two partially 
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overlapping open reading frames, one from nucleotide 
22 to 1,425, and a second from nucleotide 1,370 to 
1,729. The first one contained a potential start codon at 
nucleotide 22 and coded for a protein of 51.5 kDa, 10 
kDa smaller than rat liver regulatory protein. Partial 
sequencing of another long clone indicated that it corre- 
sponded to nucleotides 5 1 to 2,081 of PBS-LPR17. This 
clone contained however a stretch of 4 thymidines in- 
stead of 5 as found at position 1,41 l-1,41 5 of PBS- 
LPRI 7. This change extended the longest open reading 
frame by an additional 300 nucleotides, bringing the 
predicted molecular mass of the encoded polypeptide to 
a value of approximately 63 kDa. 
Two positive clones, termed PBS-ZPRl and 2, were 
obtained from the Stratagene library. Both clones con- 
tained only 4 T at position 1,411-1,414 of PBS-LPR17, 
confirming that the fifth T was the result of a mutation 
as can be found at sites of reiterated bases [17]. PBS- 
ZPRl, which was completely sequenced, corresponded 
to nucleotides 45-2,101 of PBS-LPR17, plus 9 nucleo- 
tides and a poly A-tail of 45 residues at its 3’ end. In 
addition, this clone contained a G-to-A transition at 
position 924, which did not affect the deduced amino 
acid sequence. PBS-ZPR2, which was only partially se- 
quenced, corresponded to nucleotides 55-2,101 of PBS- 
LPR17, plus an additional 15 nucleotides, but without 
poly-A tail. 
Fig. 1B shows the sequence of the cDNA that could 
be reconstructed from the various clones, as well a the 
deduced protein sequence. The initial ATG codon is 
surrounded by a sequence similar to the Kozak consen- 
sus sequence (GCC(A/G)CCATGG). Identification of 
this ATG as the start codon was conflrmed by sequenc- 
ing of the NH,-terminus of rat liver regulatory protein. 
The obtained sequence (XGTKRYQXVIETPEPGE) 
corresponded to amino acids 2-18 of the deduced se- 
quence, indicating that the initiator methionine of the 
regulatory protein was excised in vivo, as is often ob- 
served [18]. The open reading frame encoded a protein 
of 568 amino acids (excluding the initiator methionine), 
in which the sequence of the four peptides can be iden- 
tified. The predicted molecular mass is 62,867 Da, in 
good agreement with the mass of regulatory protein 
purified from rat liver. Interestingly, the C-terminus of 
the protein is a basic tetrapeptide, Arg-Arg-Lys-Arg. 
The same sequence is found internal in retroviral enve- 
lope proteins, where it serves as a cleavage signal for 
proteolytic processing [19]. A similar sequence (Arg- 
Lys-Arg-Arg) serves a similar role in the insulin recep- 
tor precursor protein [20]. Due to its position, the basic 
tetrapeptide cannot play this role in liver regulatory 
protein. It could, however, participate in the interaction 
of this protein with glucokinase, as this interaction was 
shown to be partially ionic in nature [8]. Sequence com- 
parisons did not reveal a significant degree of similarity 
with other DNA (GenBank release no. 73) or protein 
(Swissprot release no. 23) sequences. 
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GAGGGTCCACAGTGTGGGACCATGCCAGGCACCAAACGATATCAGCATGTGATCGAGACCCCTGAGCCTGGTG~TGGGAGTTGTCAGGG 
MPGTKRYQHV IETPEPGEWELSG 
TATGAAGCGGCTGTGCCAATCACAGAGAAATCCAACCCACTGACCCGAAACCTGGACAAAGCAGATGCAGAGAAAATTGTCAAACTGCTG 
YEAAVPITEKSNPLTRNLDKADAEKIVKLL 
GGGCAGTGTGATGCTGAGATATTCCAGGAGGAGGGGCAGATTGTGCCCACCTACCAGCGACTATACAGCGAATCAGTTCTGACCACCATG 
GQCDAEIFQEEGQI VPTYQRLYSESVLTTM 
TTGCAAGTGGCTGGAAAAGTCCAGGAAGTTCTGAAGGAGCCAGATGGGGGTCTGGTAGTGCTGAGTGGAGGGGGAACCTCTGGTCGTATG 
LQVAGKVQEV LKEPDGGLVVLSGGGTSGRM 
GCATTTCTCATGTCTGTGTCTTTCAACCAGCTGATGAAAGGCCTGGGACAAAAGCCTCTTTACACCTACCTCATTGCAGGAGGTGACAGG 
AFLMSVSFNQLMKGLGQKP LYTYLIAGGDR 
TCTGTTGTGGCCTCTCGTGAAGACAGAAGATACCGCGCCCTACACGGGATCGAGGAGCTGAAGAAGGTGGCTGCTGGGAAGAAGAGAGTG 
SVVASREQTEDSALHG IEELKKVAAGKKRV 
GTCGTCATAGGCATCTCTGTGGGACTCTCTGCGCCCTTTTGTGGCAGGTCAGATGGACTACTGCATGGATAACACAGCCGTCTTCTTGCCG 
V V I G ISVGLSAPFVAGQMDYCMDN TAVFLP 
GTTCTGGTTGGCTTCAATCCAGTGAGCATGGCCAGAAATGACCCCATTGAAGACTGGAGATCAACATTCCGGCAAGTGGCAGAGCGGATG 
VLVGFNPVSMARNDP IEDWRSTFRQVAERM 
CAAAAGATGCAGGAGAAACAGGAAGCTTTTGT~CTCAATCCTGCCATCGGGCCCGAGGGGCTCAGCGGCTCTTCCCGAATGAAAGGTGGA 
QKMQEKQEAFVLNPAIGPCGLSGSSRMKGG 
GGTGCCACCAAGATTCTACTGGAAACCCTGCTACTAGCAGCCCATAAGACTGTGG ?CCA GGTGTTGTGTCCTCTCAAAGATGCCTTCTG 
GATKILLETLLLAAHKTVDQGVVS SQRCLL 
GAAATCCTGAGGACATTTGAGCGCGCTCATCATCAGGTGACCTACAGTCAAAGTTCCAAAATTGCCACGCTGATGAAACAAGTCGGCATCAGC 
EILRTFERAHQVTYSQSSKI ATLMKQVGIS 
CTGGAGAAGAAAGGCCGAGTGCACTTGGTTGGCTGGCAGACTCTCGGCATCATTGCCATTATGGACGGAGTAGAGTGCATCCACACTTTT 
LEKKGRVHLVGWQTLG IIAIMDGVECIHTF 
GGTGCTGATTTCCAAGATATCCGTGGCTTTCTTATTGGTGACCACAGTGACATGTTTAACCAGAAGGATGAACTCACCAACCAGGGTCCC 
GADFQDIRGFLIGDHSDMFNQKDE LTNQGP 
CAGTTCACCTTCTCCCAGGATGACTTCCTGACTTCCATCCTGCCATCCCTCACGGAGACTGACACCGTGGTCTTCATTTTTACCCTGGAT 
QFTFSQDDFLTSILPSLTETDTVVFIFTLD 
GATAACCTCACAGAAGTACAGGCCCTGGCAGAAAGAGTGAGAGAGAAGTGCCAGAACATCCAGGCCCTGGTGCACAGCACTGTGGGGCAG 
DN LT EVQA LAERVREQN I QA L*VHS TVGQS L 
TCCTTGCCGGCCCCTCTAAAGAAACTCTCTTTCCCTCACTCATCAGTATCACGTGGCCACTTCTTTTCTTCGATTATGAAGGGACCTATGTT 
PAPLKCKKLFPSLISITWPLLFFDYEGTYV 
CAGAAGTTCCAGCGTGAGTTAAGCACCAAGTGGGTGTTGAATACAGTGAGTACTGGGGCCCATGTACTGCTGGGGAAGATCCTACAGAAC 
QKFQRELSTKWVLNTVSTGAHVLLGKILQN 
CACATGCTGGACCTCCGCATCGCCAACTCCAAGCTCTCTTCTGGAGGGCGCTGGCCATGTTGCAGAGGTTCTCTGGACAGTCCAAGGCTCGC 
HMLDLRIANSKLFWRALAMLQRFSGQSKAR 
TGCATTGAGAGCCTCCTTCAAGCAATCCACTTTCCTCAACCACTGTCGGATGATGTCGCGCCGCTCCCATCTCCTGCCACGTCCAGGTTG 
CIESLLQAIHFPQPLSDDVAPLPSPATSRL 
CCCACGAGAAGGAAAAGGTGATCCCCACAGCCTTGCTGAGCCTCCTACTCCGGTGCTCCATCTCTGAGGCTAAGGCACGCCTGTCTG'CAG 
PTRRKR 
CTTCTTCAGTCTGTGAGGTTGTTAGGAGCGCCCTCTCTGGGCCGGGTCAGAAGCGCAGCACGCAAGCCCTTGAAGACCCTCCCGCCTGTG 
GGACCCTGAATTGATATTTCTAGAACCATGGAGGGGCAGAGTCTCCGTCCACTTCCAAGGGGACATGTGCCAGCAGTACACGCTGTGGGA 
AGAACTCAGTTTCGGGTGGGTGGGGCCTAACTGCCCAGAACCGGATTATTTCCATTTTTACTGGTGT 
CTTCTGAACTCAGAAATAAAACTAAATGTCTTGTTTTGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA~~AA~AAA 
90 
180 
270 
360 
450 
540 
630 
720 
810 
900 
990 
1080 
1170 
1260 
1350 
1440 
1530 
1620 
1710 
1800 
1890 
1980 
2070 
Fig. 1. Sequencing strategy and sequence of the cDNA encoding rat liver regulatory protein. (A) Sequencing was performed on s&clones, or using 
specific primer(s). (B) Nucleotide and deduced amino acid sequence. The asterisk indicates the position where an additional T was found in 
pBSLPR17. The sequences of the tryptic peptides are underlined. 
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Li Lu Ki Mu combinant protein present in extracts of cells did not 
inhibit glucokinase. Our attempts to renature the regu- 
latory protein present in inclusion bodies by dilution 
from concentrated urea solutions [21] were so far unsuc- 
cessful. 
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a-- 2.35 kb 
Fig. 2. Northern blot analysis of different tissues. Twenty pg of total 
RNA was loaded per lane. Li, liver; Lu, lung; Ki, kidney; Mu, muscle. 
3.2. Northern blot analysis 
As shown in Fig. 2, Northern blot analysis revealed 
the existence in rat liver of a major 2.35 kb transcript, 
and a minor 3.9 kb band, possibly an immature tran- 
script. A faint signal with a size of 2.35 kb was also 
observed in some lung samples (+ 3% of the rat liver 
signal). No positive signal was observed with RNA 
from skeletal muscle, brain, intestine, testis, spleen and 
heart. These results are consistent with the presence of 
regulatory protein in liver but not in other tissues. 
3.3. Expression of regulatory protein in bacteria 
The coding sequence of the regulatory protein was 
reconstructed from PBS-LPR 17 and PBS-ZPR 1 and in- 
serted in the expression vector pET3a [13]. The resulting 
recombinant plasmid was introduced in E. coli BL21 
(DE3)pLysS. Addition of isopropylthiogalactoside to 
the culture medium resulted in the appearance of a ca. 
60 kDa polypeptide in the cells harboring the recombi- 
nant plasmid although not in cells containing the ex- 
pression vector without the insert (not shown). Western 
blots indicated that this 60 kDa protein cross-hybrid- 
ized with antibodies directed against rat liver regulatory 
protein (not shown). The majority of the recombinant 
protein present in cell-free extracts sedimented upon a 
10 min centrifugation at 5,000 x g, indicating that it was 
present in inclusion bodies. Attempts at obtaining a 
soluble recombinant protein by lowering the tempera- 
ture during induction (22°C) or by lowering the concen- 
tration of isopropylthiogalactoside failed. 
Not surprisingly because of its insolubility, the re- 
To confirm that the product of the cloned gene corre- 
sponded to the regulatory protein of glucokinase, we 
electrophoresed the recombinant protein and trans- 
ferred it onto a nitrocellulose membrane. Strips corre- 
sponding to the major band were used to immunopurify 
antibodies [9]. These purified antibodies were found to 
ABCDEF 
10m3 x Mr 
+ 69 
+ 46 
Fig. 3. Western blot analysis of rat liver regulatory protein and of 
recombinant regulatory protein. The following samples were electro- 
phoresed: Lanes AX 5 (A), 1 (B) and 0.2 (C) U of regulatory protein 
purified from rat liver [2], corresponding to ca. 1, 0.2 or 0.04 pg pure 
protein. Lanes D-F: similar amounts of the recombinant 60 kDa 
protein as in lanes A-C, as judged from a Coomassie blue-stained gel. 
The blot was developed with antibodies imnmnopurified [9] on immo- 
bilized recombinant regulatory protein. 
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react with regulatory protein purified from rat liver and 
with recombinant regulatory protein with similar sensi- 
tivity. These results indicated that the cloned cDNA 
does not correpond to a protein that would still contam- 
inate our preparation of apparently homogeneous regu- 
latory protein. The molecular mass of the recombinant 
protein is slightly smaller than that of the protein puri- 
fied from liver. This could be due to proteolysis of the 
first, or to post-translational modification of the latter. 
As a conclusion, we have obtained the cDNA con- 
taining the entire coding sequence of rat liver regulatory 
protein. Our identification is based on: (1) the identity 
between partial peptide sequences obtained from homo- 
geneous regulatory protein and the sequence deduced 
from the cDNA; (2) the good agreement between the 
mass of the regulatory protein purified from rat liver 
and the recombinant protein; (3) the recognition of the 
recombinant regulatory protein by antibodies directed 
against rat liver regulatory protein. 
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